Brazil researchers report more modest 50.4% efficacy for China’s CoronaVac

A coronavirus vaccine developed by China’s Sinovac showed “general efficacy” of 50.4% in a late-stage trial in Brazil, the company’s local partners said on Tuesday, revealing a more modest figure …
( read original story …)